These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19350076)

  • 21. Educational and health service needs of Australian general practitioners in managing hepatitis C.
    Gupta L; Shah S; Ward JE
    J Gastroenterol Hepatol; 2006 Apr; 21(4):694-9. PubMed ID: 16677155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty or thirty microgram ethinyloestradiol in an oral contraceptive: does it make a difference in the mind and the daily practise of gynaecologists and general practitioners?
    Bitzer J; Frey B; von Schönau M; Sabler N; Tschudin S
    Eur J Contracept Reprod Health Care; 2009 Aug; 14(4):258-67. PubMed ID: 19513939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in women's attitudes towards and use of hormone therapy after HERS and WHI.
    Hoffmann M; Hammar M; Kjellgren KI; Lindh-Astrand L; Brynhildsen J
    Maturitas; 2005 Sep; 52(1):11-7. PubMed ID: 16023804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women's use of hormone therapy before and after the Women's Health Initiative: a psychosocial model of stability and change.
    Gerend MA; Aiken LS; Erchull MJ; Lapin A
    Prev Med; 2006 Sep; 43(3):158-64. PubMed ID: 16750263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003.
    Hing E; Brett KM
    Obstet Gynecol; 2006 Jul; 108(1):33-40. PubMed ID: 16816053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The woman patient after WHI.
    Graziottin A
    Maturitas; 2005 May; 51(1):29-37. PubMed ID: 15883106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in preventive medicine among general practitioners, 1984-1990.
    Corney R
    Health Trends; 1993-1994; 25(4):139-42. PubMed ID: 10133876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of informational interventions about cognitive behavioral therapy for chronic fatigue syndrome on GPs referral behavior.
    Scheeres K; Wensing M; Mes C; Bleijenberg G
    Patient Educ Couns; 2007 Sep; 68(1):29-32. PubMed ID: 17521842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey.
    Buhling KJ; von Studnitz FS; Jantke A; Eulenburg C; Mueck AO
    Menopause; 2012 Oct; 19(10):1088-91. PubMed ID: 22692331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy.
    Hovi SL; Karttunen T; Karro H; Hemminki E
    Maturitas; 2004 Oct; 49(2):107-13. PubMed ID: 15474754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [General practitioners' perception of disease risks and benefit of prevention].
    Nexøe J; Gyrd-Hansen D; Kragstrup J; Kristiansen IS; Nielsen JB
    Ugeskr Laeger; 2002 Nov; 164(46):5379-82. PubMed ID: 12469383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hospitalisations at the end of life: using a sentinel surveillance network to study hospital use and associated patient, disease and healthcare factors.
    Van den Block L; Deschepper R; Drieskens K; Bauwens S; Bilsen J; Bossuyt N; Deliens L
    BMC Health Serv Res; 2007 May; 7():69. PubMed ID: 17488520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular risk assessment in Australian general practice.
    Gupta R; Stocks NP; Broadbent J
    Aust Fam Physician; 2009 May; 38(5):364-8. PubMed ID: 19458809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An education and training course in motivational interviewing influence: GPs' professional behaviour--ADDITION Denmark.
    Rubak S; Sandbaek A; Lauritzen T; Borch-Johnsen K; Christensen B
    Br J Gen Pract; 2006 Jun; 56(527):429-36. PubMed ID: 16762124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. General practitioners' tacit and stated policies in the prescription of lipid lowering agents.
    Evans JS; Harries C; Dennis I; Dean J
    Br J Gen Pract; 1995 Jan; 45(390):15-8. PubMed ID: 7779468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolving practice patterns and attitudes toward hormone therapy of obstetrician-gynecologists.
    Power ML; Schulkin J; Rossouw JE
    Menopause; 2007; 14(1):20-8. PubMed ID: 17019376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current recommendations: what is the clinician to do?
    Manson JE
    Fertil Steril; 2014 Apr; 101(4):916-21. PubMed ID: 24680650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.